Chantix
Chantix Background:
Chantix (Varenicline) is manufactured by Pfizer. Chantix is a smoking cessation drug. Patients are prescribed Chantix to help alleviate their smoking addictions. Chantix works by reducing the pleasurable effects of tobacco products and helping to ease the pain of nicotine withdrawal. The main ingredient within Chantix acts upon the human brain.
FDA Response:
The FDA has stated that there is an association between Chantix and serious neuropsychiatric symptoms. As a result, the FDA required Pfizer to elevate the prominence of the safety information to the warning and precautions section of the Chantix prescribing information. The FDA issued a further warning to address the revisions to the warning and precautions section for Chantix regarding serious neuropsychiatric symptoms. These symptoms include changes in behavior, agitation, depressed mood, suicidal ideation, and attempted and completed suicide.
Chantix Problems:
You may have been harmed by Chantix if you have suffered the following:
- Changes in Behavior
- Agitation
- Depressed Mood
- Suicidal ideation
- Attempted/Completed Suicide
- Angiodema
- Severe skin reactions
- Visual Impairment
- Accidental Injuries
Chantix Litigation:
James, Vernon & Weeks, P.A. seeks to protect the rights of individuals who have been harmed by Chantix. James, Vernon & Weeks, P.A. represents individuals suffering from Chantix on a contingency basis. Contingency basis means that there are never any legal fees unless James, Vernon & Weeks, P.A. wins compensation in your case.
